Balance Sheet Data

Evogene Ltd. (EVGN)

$0.665

-0.01 (-2.21%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 54.4746.8848.2353.8735.3682.6193.09104.90118.21133.21
Total Cash (%)
Account Receivables 1.022.153.592.931.834.214.745.346.026.78
Account Receivables (%)
Inventories -0.44-0.19-0.26-0.24-0.43-0.48-0.54-0.61-0.69-0.77
Inventories (%)
Accounts Payable 1.0110.861.461.041.862.102.362.663
Accounts Payable (%)
Capital Expenditure -0.37-0.90-0.68-0.72-1.17-1.34-1.51-1.70-1.91-2.16
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.